ArticleRevista latino-americana de enfermagem2014
Women with breast cancer taking chemotherapy: depression symptoms and treatment adherence.
Article in Revista latino-americana de enfermagem, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Efficacy and Safety Analyses of Mirtazapine in the Treatment of Malignant Tumor Related Depression: A Phase II, Placebo-controlled, Randomized, Double-blinded Clinical Trial in Advanced Non-small Cell Lung Cancer Patients
The Psychology of Chinese Breast Cancer Patients
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Immediate impact of Mindfulness-Based Cognitive Therapy (MBCT) among women with breast cancer: a systematic review and meta-analysis.BMC women's health · 2023Pooled it
- Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients.Molecular psychiatry · 2020Pooled it
- Impact of Pre-Diagnosed Depressive Symptoms on Treatment Choice, Delay in Initiating Treatment, and Mortality Among Women Aged ≥65 Years with Breast Cancer.International journal of environmental research and public health · 2026Article
- Gender differences in the incidence of psychiatric disorders among breast cancer patients: a nationwide cohort study.Epidemiology and psychiatric sciences · 2026Article
- Psychosomatics at the threshold: cancer, mood disorders, and the mental pain of death - where precision medicine meets spirituality.Frontiers in psychiatry · 2026Article
- Deep learning predicts the effect of neoadjuvant chemotherapy for patients with triple negative breast cancer.Journal of pathology informatics · 2025Article
- Adherence to chemotherapy and associated factors among adult patients with cancer in the Amhara region, Ethiopia, 2022.Discover oncology · 2025Article
- Joint association of dietary live microbe intake and depression with cancer survivor in US adults: evidence from NHANES.BMC cancer · 2025Article
- Machine learning-driven survival prediction in gestational trophoblastic neoplasms: a focus on PSTT and ETT prognosis.Frontiers in oncology · 2024Article
- An examination of health care utilization during the COVID-19 pandemic among women with early-stage hormone receptor-positive breast cancer.BMC health services research · 2022Article
- Psychosocial distress is dynamic across the spectrum of cancer care and requires longitudinal screening for patient-centered care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- Article
- Understanding care needs of cancer patients with depressive symptoms: The importance of patients' recognition of depressive symptoms.Psycho-oncology · 2022Article
- Depression and survival of breast cancer patients: A protocol for systematic review and meta-analysis.Medicine · 2020Article
- Article
- The Quality of Life and Degree of Depression of Patients Suffering from Breast Cancer.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2018Article
- Adherence to Chemotherapy and Associated Factors Among Patients With Cancer in Amhara Region, Northeastern Ethiopia, 2022. A Cross-Sectional Study.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo verify depressive symptoms and adherence to chemotherapy among women with breast cancer who are served by the Pharmacy of the Chemotherapy Center of a university hospital.
methodCross-sectional study with quantitative approach conducted with 112 women receiving chemotherapy. Structured interviews guided by a script addressing socio-demographic, clinical and therapeutic information, the Morisky Test, and the Beck Depression Inventory were used to collect data.
results12.50% and 1.78% of the patients experienced "moderate" and "severe" depression, respectively, while 10.59% did not use antidepressant medication. A statistically significant association was found between levels of depression and the use of antidepressants. Lack of adherence was identified in 46.43% of the participants.
conclusionThese findings show the need to regularly screen for depressive symptoms and for adherence to chemotherapy treatment among women with breast cancer, in order to provide early detection and appropriate treatment centered on patients, and to improve their quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.